Companies
Eli Lilly's Mounjaro Hits R$13.5 Billion in First Year in Brazil, Reshaping Obesity Drug Market
Demand for tirzepatide outstripped expectations, boosting the Brazilian unit into Eli Lilly's global top 10, but looming...
Declan Byrne
👁 3
💬 0
